Stay updated with breaking news from Martina flammer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockWatch: Insmed Shares Leap 150%, as Analysts See Next Blockbuster genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.
Insmed Announces Positive Topline Results from Landmark ASPEN Study of Brensocatib in Patients with Bronchiectasis prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
-Phase 3 Study Achieves Primary Endpoint for Both Dosage Strengths of Brensocatib with Statistically Significant and Clinically Meaningful Reduction in Frequency of Pulmonary Exacerbations Versus ....
/PRNewswire/ Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare. ....
On January 12, 2024, Martina Flammer, Chief Medical Officer of Insmed Incorporated (NASDAQ:INSM), sold 4,667 shares of the company's stock, according to a recent SEC filing. ....